GRP and pachyonychia congenita: Among the 80 PC specimens tested using 125I-Tyr4-bombesin receptor binding assays, 63% exhibited high-affinity and low-volume binding sites for bombesin/GRP, with 12 receptor-positive samples displaying two types of binding sites.